strong
associ
infectionrel
cellmedi
immun
autoimmun
diseas
diabet
multipl
sclerosi
ms
rheumatoid
arthriti
ra
lupu
erythematosi
sle
infect
also
associ
unusu
immunopatholog
unknown
origin
wegner
granulomatosi
sarcoidosi
coliti
pannicul
bronchiol
obliteran
even
chronic
fatigu
syndrom
despit
exhaust
effort
definit
link
one
particular
pathogen
one
patholog
never
found
often
sever
pathogen
becom
associ
condit
instanc
multipl
sclerosi
associ
epstein
barr
viru
ebv
measl
viru
varicellazost
viru
picornavirus
pannicul
form
erythema
nodosum
bronchiol
obliteran
associ
unusu
cellmedi
immun
respons
occur
follow
nonspecifi
viral
intracellular
bacteri
infect
erythema
nodosum
also
associ
crohn
diseas
pain
condit
nodul
inflam
subcutan
fat
often
shin
forearm
persist
month
known
therapi
bronchiol
obliteran
lethal
condit
human
bronchiol
becom
occlud
immun
cell
fibrin
materi
known
caus
treatment
chronic
fatigu
syndrom
cf
anoth
unusu
multisystem
diseas
thought
associ
immun
dysregul
past
two
decad
million
patient
world
wide
suffer
clinic
syndrom
disabl
fatigu
myalgia
palpit
cognit
dysfunct
last
longer
month
case
develop
mild
viral
ill
case
may
appear
sporad
cluster
mani
attempt
made
defin
syndrom
basi
etiolog
agent
agent
includ
epsteinbarr
viru
brucella
candida
albican
borrelia
burgdorferi
human
recent
associ
enterovirus
xenoretrovirus
gener
conclus
unlik
syndrom
caus
singl
etiolog
agent
mechan
mediat
cf
poorli
understood
well
design
studi
examin
caus
symptom
cf
similar
experienc
viral
infect
infecti
mononucleosi
influenza
set
therapi
cytokin
interferon
specul
symptom
reflect
alter
immun
respons
pathogen
product
one
cytokin
altern
hypothesi
suggest
number
infecti
agent
involv
result
regulatori
imbal
cytokin
patient
cf
unabl
reestablish
appropri
balanc
cytokin
theori
support
report
immun
defici
seen
associ
cf
much
effort
place
tri
identifi
b
cell
autoantigen
respons
autoimmun
respons
often
limit
success
seem
last
year
made
slow
progress
understand
pathogenesi
autoimmun
diseas
syndrom
unknown
origin
purpos
review
call
collect
autoimmun
syndrom
review
would
like
suggest
differ
perspect
tri
understand
mechan
behind
diseas
examin
evid
date
argu
specif
pathogen
immun
respons
lead
dysregul
immun
system
specif
autoantigen
respons
autoimmun
diseas
instead
would
like
suggest
better
understand
pathogenesi
classic
autoimmun
diseas
unusu
immunopatholog
unknown
origin
often
consid
autoimmunelik
syndrom
requir
evalu
cell
regul
evolv
multipl
sequenti
infect
influenc
heterolog
immun
cell
respons
viral
infect
extraordinarili
dynam
highli
variabl
individu
cell
respons
impact
previou
infect
put
unrel
virus
subsequ
viral
infect
modul
memori
cell
pool
creat
respons
previous
encount
pathogen
concept
heterolog
antivir
cellmedi
immun
take
account
influenc
cell
respons
one
viru
anoth
review
necess
focu
predominantli
cell
respons
gener
known
epitopespecif
cell
respons
pathogen
data
present
indic
heterolog
immun
alter
outcom
new
infect
determin
whether
infect
subclin
progress
sever
immunopatholog
death
even
genet
ident
mice
although
superfici
may
seem
complex
behoov
us
better
understand
gener
principl
heterolog
immun
ever
go
understand
mechan
behind
aberr
immun
respons
best
interven
addit
improv
understand
aberr
immunopatholog
diseas
import
public
healthrelev
question
receiv
consider
attent
viral
immunologist
one
design
success
cell
vaccin
give
long
term
protect
immun
without
immunopatholog
particularli
elderli
circumst
viru
infect
induc
sever
immunopatholog
way
circumv
type
immunopatholog
contribut
develop
autoimmun
figur
properti
virus
infect
cell
peptid
cleavag
product
mani
encod
protein
get
incorpor
nascent
class
major
histocompat
complex
mhc
molecul
get
present
cell
surfac
cell
bear
cell
receptor
tcr
specif
peptidemhc
complex
result
viral
infect
frequent
stimul
potent
class
irestrict
cell
respons
capabl
perforinor
fasldepend
cytotox
interferon
ifn
tnf
product
inde
cell
essenti
regul
viral
infect
play
import
role
clearanc
virusinfect
cell
sometim
caus
damag
immunopatholog
rel
balanc
protect
immun
immunopatholog
often
determin
fate
virusinfect
host
figur
dendrit
cell
dc
present
viral
antigen
costimulatori
signal
cell
caus
releas
cell
growth
factor
ie
initi
program
expans
requir
addit
exposur
antigen
howev
presenc
antigen
factor
produc
helper
cell
may
modul
process
contract
respons
virusspecif
cell
save
memori
undergo
steadi
state
homeostat
prolifer
earli
phase
viru
infect
dramat
reduct
lymphocyt
number
associ
high
level
type
interferon
ifn
depend
apoptosi
particularli
memori
phenotyp
cell
follow
complet
viral
infect
frequenc
previou
memori
cell
popul
crossreact
new
pathogen
declin
gener
studi
shown
infect
unrel
viru
induc
format
new
memori
cell
specif
second
viru
delet
memori
cell
specif
previous
encount
viru
perman
chang
remain
lifetim
mous
though
never
demonstr
suffici
studi
human
use
immsim
discret
model
virtual
immun
system
propos
two
model
explain
loss
memori
cell
frequenc
passiv
attrit
model
wherebi
old
memori
cell
lost
simpli
competit
newli
form
memori
cell
surviv
nich
immun
system
immun
respons
silenc
activ
attrit
model
wherebi
direct
apoptosi
preexist
memori
cell
vivo
data
support
activ
attrit
model
great
major
cell
respond
direct
discret
number
immunodomin
peptid
depend
number
factor
includ
frequenc
avail
cell
specif
peptidemhc
combin
cell
frequenc
depend
thymic
select
also
function
whether
host
experienc
cell
expans
ident
nonhomolog
crossreact
epitop
pattern
immunodomin
viru
infect
thu
greatli
alter
previou
exposur
virus
may
encod
crossreact
epitop
specif
cell
degener
calcul
singl
tcr
potenti
react
mani
peptidemhc
combin
welldocu
mani
virusspecif
cell
crossreact
epitop
encod
virus
uninfect
target
display
allogen
mhc
antigen
recent
paper
elegantli
analyz
crossreact
epitop
other
defin
conclud
seemingli
distinct
epitop
low
amino
acid
sequenc
ident
biochem
similar
point
author
could
predict
two
peptid
may
crossreact
author
conclud
cell
crossreact
common
previous
thought
immsim
discret
model
virtual
immun
system
predict
earli
activ
attrit
memori
cell
may
reduc
impact
crossreact
cell
respons
anoth
pathogen
level
play
field
thu
allow
divers
immun
respons
comput
model
predict
without
apoptosi
memori
cell
earli
stage
infect
crossreact
cell
might
domin
respons
infect
select
reduc
frequenc
memori
cell
begin
immun
respons
actual
may
develop
divers
cell
respons
new
pathogen
divers
may
benefici
host
control
pathogen
abl
test
predict
vivo
elderli
mice
undergo
less
ifndriven
cell
attrit
young
mice
elderli
mice
develop
higher
number
crossreact
cell
respons
influenza
iav
immun
mice
challeng
lymphocyt
chorimening
viru
lcmv
lcmvimmun
mice
challeng
pichind
viru
pv
hierarchi
cell
respons
immunodomin
epitop
immunolog
naiv
genet
ident
mice
consist
amino
acid
sequenc
tcr
respond
epitop
differ
mous
mous
sometim
call
privat
specif
cell
repertoir
common
individu
tcr
usag
common
amino
acid
sequenc
motif
public
specif
differ
individu
sequenc
privat
specif
thu
genet
ident
host
ident
twin
consequ
random
dna
recombin
event
genet
differ
immun
system
divers
tcr
usag
pose
challeng
one
consid
whether
epitopespecif
cell
respons
may
crossreact
anoth
epitop
expand
clone
virusspecif
cell
differ
individu
may
differ
privat
specif
one
individu
may
repertoir
crossreact
two
epitop
wherea
individu
may
may
help
explain
instanc
concord
rate
twin
mani
autoimmun
diseas
diabet
multipl
sclerosi
usual
exceed
shown
privat
specif
integr
part
heterolog
immun
demonstr
genet
ident
mice
use
differ
crossreact
cell
respons
result
tremend
variabl
diseas
order
demonstr
privat
specif
memori
cell
one
lcmvimmun
mous
adopt
transfer
three
congen
recipi
found
three
mice
use
similar
crossreact
cell
repertoir
upon
vaccinia
vv
pv
challeng
howev
differ
memori
donor
would
gener
complet
differ
crossreact
respons
question
still
remain
exactli
heterolog
immun
respons
particular
crossreact
cell
respons
alter
pathogenesi
viral
diseas
condit
sequenti
infect
persist
infect
strong
associ
correl
crossreact
cell
play
role
heterolog
immun
tabl
summar
mous
studi
regard
tabl
summar
human
studi
demonstr
heterolog
immun
may
consider
signific
iav
ebv
dengu
hcv
viral
infect
human
review
examin
studi
detail
also
touch
role
model
immun
system
discret
model
immsim
may
play
help
us
understand
complex
issu
term
heterolog
immun
use
describ
differ
protect
immun
immunopatholog
mice
immun
one
viru
later
challeng
either
five
virus
iav
lcmv
pv
vv
murin
cytomegaloviru
mcmv
tabl
recent
direct
evid
publish
heterolog
immun
mediat
crossreact
cell
crossreact
cell
may
caus
dramat
differ
celldepend
protect
immunopatholog
fat
lung
wlodarczyk
mf
selin
lk
unpublish
heterolog
immun
provid
partial
protect
immun
experiment
model
provid
differ
life
death
infect
individu
exampl
lcmvimmun
mice
control
pv
infect
due
crossreact
cell
specif
subdomin
epitop
chen
welsh
rm
selin
lk
unpublish
lcmvimmun
mice
also
manifest
strong
protect
immun
infect
larg
dna
poxviru
vv
compar
mice
heterolog
immun
prevent
mortal
otherwis
lethal
dose
vv
adopt
transfer
studi
demonstr
cell
lcmvimmun
mice
requir
transfer
protect
immun
naiv
mice
challeng
pv
vv
select
expans
lcmvspecif
memori
cell
upon
vv
infect
suggest
possibl
crossreact
cell
respons
two
virus
fact
vvspecif
cell
epitop
identifi
mice
search
sequenc
similar
potenti
crossreact
lcmv
epitop
crossreact
cell
lcmvimmun
mice
mediat
protect
immun
vv
demonstr
adopt
transfer
cell
line
howev
cell
mediat
protect
immun
also
substanti
immunopatholog
classic
exampl
lcmv
clone
cell
respons
viral
clearanc
mediat
sever
leptomening
viru
replic
brain
patholog
induc
cell
acut
infect
like
result
inflammatori
condit
brought
presenc
high
number
cell
lyse
infect
tissu
via
perforin
fasl
produc
proinflammatori
cytokin
includ
tnf
chemokin
recruit
even
cell
import
factor
rapidli
viru
clear
effici
activ
cell
avid
tcr
interact
ligand
one
factor
lead
induct
high
potenc
cell
function
studi
alter
peptid
ligand
apl
show
cell
clone
highand
lowpot
ligand
differ
length
time
tcr
interact
mhcligand
often
refer
affin
tcr
high
avid
agonist
tcr
interact
cell
clone
shown
result
strong
signal
activ
full
function
potenti
cell
includ
cytokin
product
cytotox
prolifer
low
avid
weak
agonist
induc
cell
clone
produc
cytokin
prolifer
cell
clone
induc
function
requir
ligand
one
easili
imagin
low
avid
tcr
interact
crossreact
ligand
may
produc
differ
cytokin
differ
amount
cytokin
less
effici
kill
prolifer
high
avid
interact
origin
induc
ligand
recent
work
use
mutat
b
restrict
siinfekl
epitop
ovalbumin
ovalbuminspecif
transgen
cell
indic
low
affin
cell
initi
expand
kinet
similar
high
affin
naiv
cell
leav
lymph
node
earlier
sustain
expans
higher
affin
cell
clone
eventu
compet
low
affin
clone
domin
respons
although
exact
mechan
ligand
bind
transmiss
extracellular
interact
product
intracellular
signal
sequenc
remain
incomplet
known
mani
year
immunoreceptor
tyrosin
activ
motif
itam
tcell
receptor
tcr
complex
requir
initi
signal
cascad
remain
unclear
tcr
complex
requir
itam
mani
itamcontain
immun
receptor
fc
receptor
fcr
b
cell
receptor
bcr
contain
far
fewer
itam
vignali
colleagu
recent
demonstr
variou
paramet
cell
develop
activ
influenc
number
well
locat
type
itam
within
tcr
complex
henc
propos
tcr
capabl
scalabl
signal
facilit
initi
orchestr
divers
tcell
function
work
would
suggest
rather
simpli
signal
initi
individu
itam
may
also
respons
differenti
recruit
signal
regulatori
molecul
ultim
affect
tcell
develop
activ
differenti
unexpectedli
heterolog
immun
protect
homolog
immun
elicit
high
avid
cell
antibodi
respons
previous
encount
pathogen
recruit
larg
number
lower
avid
crossreact
memori
cell
earli
infect
heterolog
viru
might
conduc
amplifi
potent
proinflammatori
respons
presenc
go
viral
replic
due
inabl
effici
clear
viru
thu
lead
enhanc
immunopatholog
due
competit
cell
give
rise
immunodomin
low
avid
crossreact
memori
cell
may
also
prevent
develop
effect
highavid
cell
respond
normal
immunodomin
epitop
diseas
outcom
ultim
base
fine
balanc
number
memori
cell
recruit
site
viral
replic
effici
cell
clear
viru
length
time
cell
present
amplifi
proinflammatori
respons
abl
clear
viru
figur
exampl
review
focu
demonstr
fine
balanc
exist
within
heterolog
immun
includ
vv
infect
lcmvimmun
mice
price
partial
protect
cell
immun
alter
immunopatholog
intraperiton
inocul
lcmvimmun
mice
challeng
vv
develop
necrosi
viscer
fat
term
acut
fatti
necrosi
pannicul
form
pannicul
analog
human
erythema
nodosum
weberchristian
diseas
also
respiratori
infect
model
reduc
mortal
lcmvimmun
mice
infect
vv
accompani
alter
lung
patholog
lung
significantli
infiltr
lcmvspecif
cell
contribut
obstruct
bronchiol
fibrin
inflammatori
cell
bronchiol
obliteran
mention
human
erythema
nodosum
bronchiol
obliteran
unknown
etiolog
seen
viral
bacteri
infect
also
associ
autoimmun
diseas
erythema
nodosum
observ
vaccin
smallpox
hepat
b
develop
bronchiol
obliteran
lung
allograft
associ
transplant
reject
human
cell
crossreact
exist
major
immunodomin
epitop
iav
viru
ebv
substanti
part
acut
ebvspecif
cell
respons
infecti
mononucleosi
mediat
cell
crossreact
iav
contribut
induct
infecti
mononucleosi
studi
correl
fulmin
hepat
crossreact
cell
respons
iav
hcv
suggest
role
crossreact
cell
sever
dengu
viru
infect
heterolog
immun
crossreact
cell
respons
pathogen
may
basi
greatli
dysregul
immun
respons
enhanc
immunopatholog
contribut
induct
autoimmun
syndrom
lcmvimmun
mice
infect
vv
one
first
mous
model
heterolog
immun
demonstr
signific
protect
immun
signific
immunopatholog
similar
human
diseas
unknown
origin
fall
nebul
categori
potenti
autoimmun
diseas
process
type
patholog
mice
develop
depend
rout
infect
lcmvimmun
mice
infect
vv
use
tradit
intraperiton
ip
rout
mice
develop
sever
pannicul
form
inflamm
necrosi
viscer
fat
tissu
presenc
lower
viru
titer
mice
infect
vv
type
abdomin
fat
patholog
seen
human
syndrom
unknown
etiolog
weberchristian
diseas
lupu
erythematosi
erythema
nodosum
benign
common
form
pannicul
involv
inflamm
subcutan
fat
tissu
interestingli
patholog
directli
associ
viral
load
figur
tremend
variat
genet
ident
individu
mice
mice
patholog
other
sever
patholog
sometim
lead
death
role
crossreact
cellsvv
infect
activ
lcmvspecif
memori
cell
popul
sought
clarifi
whether
crossreact
cell
could
mediat
either
protect
immun
andor
patholog
vv
crossreact
lcmv
epitop
vv
infect
lcmvimmun
mous
expand
lcmvspecif
cell
crossreact
specif
vv
sometim
time
would
expand
popul
lcmv
cell
search
vv
proteom
potenti
crossreact
epitop
base
sequenc
similar
found
two
within
protein
recogn
vvspecif
cell
epitopespecif
respons
protect
vv
infect
two
epitop
sequenc
similar
lcmv
respons
turn
crossreact
lcmv
half
time
vv
infect
expand
popul
cell
sometim
expand
popul
lcmv
cell
upon
adopt
transfer
lcmvimmun
splenocyt
popul
mice
variabl
respons
due
random
stochast
event
instead
reflect
privat
specif
lcmvimmun
cell
repertoir
individu
mice
adopt
transfer
three
recipi
donor
gener
specif
outgrowth
lcmv
epitopespecif
cell
recipi
differ
donor
stimul
differ
specif
result
suggest
privat
specif
lcmv
memori
popul
dictat
crossreact
epitop
would
recogn
interestingli
turn
cell
respons
k
b
restrict
epitop
crossreact
either
lcmvencod
k
b
restrict
though
cell
recogn
epitop
fact
found
network
crossreact
epitop
encod
vv
lcmv
pv
figur
also
even
though
cell
popul
crossreact
lcmvencod
epitop
part
cell
popul
crossreact
engag
cell
specif
three
lcmv
epitop
pvencod
epitop
experi
indic
epitop
specif
cell
respons
genet
ident
individu
histori
infect
influenc
privat
specif
individu
evid
crossreact
respons
mediat
protect
immun
alter
immunopatholog
histori
lcmv
infect
well
infect
bcg
pv
iav
mcmv
provid
level
protect
immun
vv
vv
titer
day
infect
lcmvimmun
mice
gener
log
lower
mice
adopt
transfer
splenocyt
lcmvimmun
mice
provid
protect
immun
vv
induc
pannicul
adopt
transfer
crossreact
cell
line
gener
stimul
lcmvimmun
cell
popul
vvencod
crossreact
epitop
also
mediat
protect
immun
vv
interestingli
presenc
crossreact
necessarili
lead
protect
immun
crossreact
line
protect
vv
furthermor
variat
presenc
level
pannicul
vvinfect
lcmvimmun
recipi
product
privat
specif
cell
lcmvimmun
host
demonstr
adopt
transfer
lcmvimmun
cell
pair
congen
recipi
still
need
determin
whether
certain
crossreact
respons
lead
protect
immun
versu
lead
immunopatholog
potenti
therapeut
tnf
blockersboth
protect
immun
induct
immunopatholog
system
seem
heavili
depend
neither
protect
immun
pannicul
occur
mice
treat
antibodi
mice
lack
receptor
pannicul
protect
immun
also
depend
tnf
shown
tnfdefici
mice
block
tnf
solubl
tnf
receptor
enbrel
nie
selin
unpublish
fact
wherea
control
vv
infect
partial
depend
tnf
mice
presenc
heterolog
protect
immun
made
resist
vv
less
depend
tnf
perhap
heterolog
immun
may
help
explain
tnf
blocker
enbrel
remicad
antitnf
antibodi
use
treatment
human
autoimmun
diseas
rheumatoid
arthriti
coliti
toler
rel
infecti
complic
protect
reciprocalheterolog
immun
necessarili
reciproc
histori
vv
infect
confer
protect
mice
lcmv
pv
mcmv
consist
observ
cfselabel
lcmvspecif
immun
cell
transfer
mice
get
infect
vv
prolifer
substanti
cfseloss
vvimmun
cell
transfer
mice
infect
lcmv
show
littl
cell
expans
reason
unclear
far
potenti
crossreact
cell
lcmvimmun
memori
pool
cell
vvimmun
memori
pool
also
resolv
potenti
pattern
crossreact
two
virus
may
one
mani
thousand
potenti
epitop
encod
larg
vv
encod
protein
could
engag
suffici
number
memori
cell
biolog
meaning
effect
contrast
lcmv
encod
four
protein
reduc
likelihood
could
success
engag
vvspecif
memori
pool
interest
larg
virus
like
herp
simplex
viru
hsv
cmv
encod
mani
protein
interfer
class
antigen
present
thu
perhap
escap
protect
effect
heterolog
immun
remain
possibl
vvspecif
memori
cell
may
qualit
differ
lcmvspecif
memori
cell
instanc
differ
cytokin
play
role
cell
matur
vvspecif
cell
develop
presenc
lcmvspecif
cell
develop
opposit
condit
high
low
long
term
effect
cytokin
respons
memori
cell
uncertain
said
vv
infect
readili
expand
popul
vvspecif
memori
cell
indic
capabl
excel
recal
respons
heterolog
immun
lcmv
vv
also
studi
respiratori
infect
common
rout
entri
virus
natur
respiratori
rout
intranas
infect
protect
immun
aberr
immunopatholog
acut
vv
infect
mice
character
high
viru
load
necrot
bronchiol
acut
inflammatori
neutrophil
infiltr
pulmonari
edema
sever
respiratori
distress
host
contrast
lcmvimmun
mice
vv
infect
character
reduc
viru
load
littl
pulmonari
edema
area
massiv
chronic
lymphocyt
infiltr
enhanc
bronchusassoci
lymphoid
tissu
balt
pannicul
sever
patholog
could
vari
insignific
sever
mice
present
unusu
patholog
bronchiol
obliteran
obstruct
airway
plug
fibrin
inflammatori
cell
patholog
human
highli
lethal
thought
induc
cellmedi
immun
unknown
etiolog
sometim
seen
human
follow
viral
infect
strongli
associ
lung
transplant
reject
despit
patholog
lcmvimmun
vvinfect
mice
experienc
less
respiratori
distress
due
area
lung
reason
intact
rather
edemat
fact
lcmvimmun
mice
abl
surviv
dose
vv
lethal
mice
yet
anoth
exampl
model
heterolog
immun
reveal
new
diseas
patholog
resembl
poorli
defin
autoimmun
syndrom
human
anoth
interest
featur
heterolog
immun
lcmv
vv
respiratori
infect
model
profound
deviat
virusinduc
cytokin
product
acut
vv
infect
mice
associ
high
level
proinflammatori
cytokin
decreas
level
immun
respons
cytokin
presum
presenc
crossreact
memori
cell
cytokin
level
vvinfect
lcmvimmun
mice
high
low
il
consist
concept
heterolog
immun
influenc
cytokineproduc
capac
crossreact
memori
cell
may
capac
skew
respons
new
infect
alway
question
much
heterolog
immun
mediat
exclus
crossreact
mechan
much
nonspecif
bystand
mechan
studi
conclud
memori
cell
subject
bystand
activ
cytokin
independ
tcr
signal
nonspecif
activ
cell
may
contribut
heterolog
immun
report
nonspecif
stimul
product
memori
cell
vv
infect
induc
mice
thu
protect
vv
entir
consequ
cell
crossreact
part
due
nonspecif
liber
memori
cell
studi
lcmvspecif
memori
cell
need
tcr
engag
produc
elev
level
presenc
rule
nonspecif
effect
certain
condit
also
possibl
upregul
host
mhc
ifn
cytokin
provid
low
level
tcr
signal
memori
cell
make
recept
activ
cytokin
without
engag
viral
peptid
area
need
studi
note
bcg
immun
provid
protect
immun
vv
celldepend
mechan
use
vivo
assay
vv
infect
preferenti
induc
cell
bcgimmun
mice
cell
lcmvimmun
mice
although
primari
infect
result
memori
phenotyp
cell
popul
periton
caviti
viscer
fat
pad
preferenti
bia
cell
subtyp
would
argu
nonspecif
stimul
cytokin
memori
cell
condit
natur
infect
vivo
even
though
crossreact
epitop
yet
identifi
interestingli
date
exampl
crossreact
cell
model
heterolog
immun
although
cell
due
low
affin
longer
peptid
target
could
crossreact
cell
problem
may
lie
possibl
may
broadbas
cell
crossreact
two
pathogen
coupl
rather
low
prolif
index
would
prevent
celllik
expans
aid
identif
crossreact
epitop
stand
system
clearli
show
celldepend
heterolog
immun
differ
class
pathogen
need
investig
lcmvimmun
mice
produc
lower
pv
titer
compar
mice
assum
due
crossreact
cell
respons
part
lcmvimmun
splenocyt
transfer
mice
partial
protect
pv
infect
sinc
lcmvimmun
mice
rel
resist
infect
vv
mcmv
could
argu
nonspecif
activ
memori
cell
might
mediat
protect
immun
nonspecif
mechan
work
howev
epitopeescap
variant
lcmv
reduc
abil
protect
mice
pv
chen
rm
welsh
lk
selin
unpublish
correl
protect
immun
crossreact
add
argument
protect
immun
nonspecif
phenomenon
instead
consequ
mhcrestrict
cell
crossreact
although
lcmvimmun
challeng
pv
develop
signific
patholog
associ
heterolog
immun
also
observ
pannicul
mice
pv
lcmv
immun
rechalleng
pv
chen
rm
welsh
lk
selin
unpublish
circumst
would
predict
cell
repertoir
crossreact
respons
vari
mice
due
privat
specif
would
skew
toward
lcmvspecif
second
infect
would
optim
protect
pv
lead
might
lead
immunopatholog
role
cell
crossreactivitylcmv
pv
encod
crossreact
nucleoprotein
epitop
posit
amino
acid
common
differ
amino
acid
anchor
site
k
b
mhc
might
suggest
pv
lcmv
epitop
similarli
recogn
cell
cell
gener
respons
one
viru
recogn
altern
peptid
epitop
differ
affin
suggest
tetram
bind
pattern
lcmvinduc
repertoir
almost
exclus
orient
pvinduc
repertoir
also
includ
cell
use
differ
motif
within
cell
sequenti
infect
virus
could
lead
gener
highli
variabl
skew
narrow
oligoclon
tcr
repertoir
differ
host
frequent
focus
reflect
privat
specif
cell
respons
variat
repertoir
reflect
privat
specif
pattern
rather
random
stochast
pattern
produc
program
expans
random
encount
crossreact
cell
clone
cognat
ligand
transfer
splenocyt
one
immun
mous
three
recipi
mice
infect
heterolog
viru
gener
similar
cell
repertoir
recipi
donor
gener
differ
set
repertoir
indic
repertoir
avail
crossreact
expans
establish
first
viru
infect
uniqu
immun
mous
narrow
tcr
repertoir
predict
modelingnarrow
divers
tcr
repertoir
viral
epitop
may
occur
evolut
perfect
fit
persist
viru
infect
hiv
hcv
cmv
ebv
repeat
antigen
challeng
influenza
viru
mani
exampl
cell
crossreact
peptid
encod
differ
virus
anoth
major
caus
tcr
repertoir
restrict
could
due
crossreact
cell
respons
rather
narrow
subset
epitopespecif
cell
memori
pool
select
stimul
prolifer
exposur
crossreact
pathogen
infect
heterolog
viru
highfrequ
notverydivers
set
clone
may
immunodomin
emerg
cell
respons
precursor
caus
restrict
repertoir
demonstr
lcmvimmun
mice
infect
pv
furthermor
result
use
immsim
model
incorpor
adopt
transfer
privat
specif
would
suggest
tcr
affin
play
import
role
drive
phenomenon
histori
intranas
iav
infect
mice
gener
level
protect
immun
vv
possibl
similar
mechan
lcmv
vv
describ
howev
histori
iav
infect
lead
enhanc
titer
lcmv
mcmv
alter
immunopatholog
long
known
iav
infect
break
structur
barrier
bacteri
infect
lung
bacteri
invas
lung
often
respons
mortal
human
influenza
patient
howev
mice
receiv
lcmv
mcmv
long
iav
infect
resolv
lung
longer
show
sign
structur
damag
suggest
dysregul
immun
occur
consequ
heterolog
immun
heterolog
immun
iav
lcmv
quit
complex
iavimmun
mice
develop
enhanc
replic
lcmv
enhanc
immun
patholog
lung
character
massiv
consolid
mononuclear
pneumonia
bronchiol
instead
mild
lymphocyt
pneumon
observ
lcmv
infect
mice
bronchiol
anoth
novel
patholog
observ
human
unknown
etiolog
thought
perhap
associ
lung
repair
process
memori
cell
deplet
studi
indic
enhanc
lcmv
titer
seem
depend
iavspecif
memori
cell
perhap
regul
cell
enhanc
immun
patholog
caus
crossreact
iavspecif
cell
respons
wlodarczyk
mf
selin
lk
unpublish
crossreact
epitop
iav
lcmv
defin
studi
mice
tabl
import
epitop
pattern
heterolog
immun
shown
use
variant
iav
lcmv
delet
epitop
delet
inhibit
immunopatholog
associ
heterolog
immun
addit
epitopespecif
cell
delet
function
inactiv
intraven
infus
peptid
mice
result
select
deplet
epitopespecif
memori
cell
decreas
lung
patholog
induc
heterolog
immun
also
abl
inhibit
immunopatholog
treat
iavimmun
mice
prior
challeng
lcmv
took
differ
novel
approach
help
explain
increas
sever
lung
patholog
dysregul
heterolog
immun
identif
crossreact
epitop
correl
crossreact
epitopespecif
memori
respons
diseas
sever
ablat
inappropri
crossreact
cell
respons
temporari
attenu
cell
effector
cytokin
wlodarczyk
mf
selin
lk
unpublish
four
approach
suggest
first
time
therapeut
intervent
may
possibl
circumv
sever
immunopatholog
induc
heterolog
immun
seem
highli
possibl
memori
cell
pool
skew
direct
infect
crossreact
pathogen
could
activ
induc
cytokin
secret
cell
could
alter
differenti
immun
respons
pathogen
studi
unambigu
show
though
hint
infect
balbc
mice
rsv
rsv
caus
sever
respiratori
infect
children
adult
inact
vaccin
rsv
past
result
increas
morbid
mortal
children
children
becam
natur
expos
viru
children
present
sever
lung
patholog
associ
intens
eosinophilia
presum
brought
type
cytokin
respons
involv
cellproduc
cytokin
phenomenon
mimick
mice
immun
rsv
g
protein
later
challeng
live
rsv
mice
develop
narrowli
focus
respons
associ
high
level
product
sever
eosinophilia
cell
direct
singl
gencod
epitop
rather
similar
sequenc
mice
prime
rsv
g
done
context
vvg
recombin
viru
host
first
infect
iav
vvg
longer
prime
respons
iav
provid
modest
level
heterolog
immun
vv
importantli
differ
cytokin
milieu
vvinfect
iavimmun
mice
comparison
vvinfect
mice
milieu
deviat
type
cytokin
direct
thu
possibl
iav
infect
caus
immun
deviat
vvg
immun
infect
third
viru
rsv
sever
patholog
develop
result
would
suggest
heterolog
immun
could
play
role
develop
allergi
asthma
follow
viral
infect
set
human
diseas
difficult
test
whether
heterolog
immun
play
role
protect
immun
time
direct
evid
come
epidemiolog
vaccin
studi
young
children
third
world
found
bcg
combin
live
attenu
measl
mump
rubella
mmr
vaccin
protect
unknown
manner
mortal
infecti
diseas
rotavirusinduc
diarrhea
pneumonia
interestingli
subsequ
vaccin
kill
combin
diphtheria
tetanu
pertussi
dtp
vaccin
revers
benefici
effect
fact
increas
mortal
also
data
demonstr
middleag
ebv
seroneg
adult
constantli
expos
ebv
laboratori
environ
strong
restrict
crossreact
cell
respons
iav
ebv
uniqu
repertoir
abl
produc
lyse
ebvinfect
target
watkin
et
al
unpublish
cohort
sex
worker
kenya
appear
form
protect
immun
hiv
long
continu
work
elderli
individu
may
also
complet
depend
crossreact
memori
respons
encount
new
pathogen
problem
studi
protect
effect
heterolog
immun
reduc
sick
would
normal
go
unnot
except
larg
scale
epidemiolog
studi
identif
role
heterolog
immun
induct
human
immunopatholog
approach
crossreact
respons
identifi
iav
hcv
ebv
crossreact
cell
associ
induct
either
fulmin
hepat
infecti
mononucleosi
respect
increas
report
signific
side
effect
hpv
vaccin
young
women
new
controversi
aris
parent
refus
vaccin
children
fear
side
effect
even
led
televis
documentari
recent
air
public
broadcast
network
pb
call
vaccin
war
time
complac
mani
childhood
infect
almost
disappear
due
vaccin
parent
focus
side
effect
vaccin
demand
demonstr
give
mani
vaccin
one
day
total
vaccin
year
age
safe
consid
preliminari
studi
concern
dramat
chang
cell
respons
mice
coinfect
lcmv
pv
togeth
compar
singli
immunodomin
hierarchi
two
virus
complet
alter
tremend
variabl
individu
mice
perhap
issu
examin
close
kenney
l
selin
lk
unpublish
issu
suggest
behoov
us
viral
immunologist
better
understand
sequenc
vaccin
given
ever
increas
seriou
issu
complianc
issu
recent
discuss
workshop
copenhagen
nonspecif
effect
sex
differ
vaccin
attend
intern
group
vaccinologist
form
consortium
begin
address
type
issu
summari
meet
publish
heterolog
immun
cours
difficult
studi
human
system
evid
occur
studi
done
call
heterotyp
immun
iav
system
mani
viral
strain
variant
found
cell
crossreact
variant
easi
detect
unresolv
question
import
crossreact
cell
immun
immun
patholog
associ
human
iav
infect
two
epidemiolog
studi
indic
exposur
one
strain
iav
appar
provid
level
protect
anoth
strain
iav
condit
littl
serolog
crossreact
among
iav
target
neutral
antibodi
differ
iav
strain
also
encod
extrem
conserv
epitop
epitop
gener
immunodomin
cell
respons
whether
specif
respons
provid
resist
infect
unclear
concret
exampl
heterolog
immun
unrel
human
virus
occur
iav
hcv
cell
respons
defin
hcvencod
epitop
ns
found
stimul
cell
respons
nonhcvimmun
individu
end
strongli
crossreact
share
amino
acid
iavencod
na
epitop
remark
studi
breadth
immun
respons
hcv
proteom
address
number
hcvinfect
patient
elispot
analys
cell
stimul
hcvencod
peptid
patient
present
broadli
reactiv
respons
signal
seen
among
larg
number
hcv
peptid
two
patient
howev
extrem
focus
respons
peptid
span
hcv
iav
crossreact
epitop
two
patient
unusu
present
hcv
infect
sever
fulmin
necrot
hepat
henc
mani
paramet
heterolog
immun
address
mous
model
play
studi
includ
narrowli
focus
crossreact
respons
associ
sever
patholog
reflect
privat
specif
patient
like
expos
iav
strain
encod
epitop
subset
mount
immunodomin
narrow
respons
unresolv
phenomenon
viral
infect
human
infect
number
virus
epsteinbarr
ebv
varicellazost
viru
measl
mump
sever
young
adult
children
usual
immun
patholog
associ
young
adult
infect
propos
one
reason
phenomenon
may
heterolog
immun
memori
cell
repertoir
children
becom
diversifi
due
acquisit
sequenc
infect
probabl
memori
cell
crossreact
anoth
pathogen
increas
may
best
cell
rapidli
clear
viru
acut
infecti
mononucleosi
aim
associ
ebv
infect
one
best
exampl
phenomenon
children
usual
subclin
infect
teenag
colleg
age
young
adult
much
sever
longer
last
infect
characterist
patholog
aim
appear
atyp
lymphocyt
fact
cytotox
granulecontain
activ
cell
respond
ebvinfect
b
cell
epitheli
tissu
evid
ebv
load
higher
aim
patient
subclin
infect
major
patholog
featur
aim
overzeal
cell
respons
effect
control
viru
mani
aim
patient
increas
frequenc
specif
cell
respons
demonstr
human
cell
crossreact
major
immunodomin
epitop
iav
ebv
find
substanti
part
acut
ebvspecif
cell
respons
aim
mediat
cell
crossreact
iav
tabl
data
demonstr
frequenc
iav
specif
cell
directli
correl
sever
infecti
mononucleosi
symptom
aslan
n
selin
lk
unpublish
broad
crossreact
cell
repertoir
predict
modelingw
examin
crossreact
respons
vitro
two
crossreact
epitop
ebv
littl
sequenc
similar
found
crossreact
repertoir
broad
rather
narrow
devoid
highli
domin
clonotyp
compar
noncrossreact
repertoir
epitop
breadth
crossreact
cell
repertoir
may
depend
variou
factor
level
similar
epitop
hypothesi
support
comput
simul
clute
sc
selin
lk
unpublish
base
earlier
observ
hypothes
high
frequenc
memori
clone
initi
immunogen
high
affin
crossreact
epitop
may
occur
epitop
similar
ie
near
crossreact
type
clone
domin
tcr
repertoir
crossreact
epitop
lead
narrow
repertoir
howev
type
clone
exist
memori
pool
may
occur
epitop
dissimilar
ie
distant
crossreact
repertoir
actual
becom
broader
without
domin
preexist
crossreact
memori
clone
crossreact
tcr
repertoir
gener
two
differ
memori
popul
first
antigen
near
crossreact
clonotyp
found
high
frequenc
posit
domin
assur
competit
develop
new
clone
thu
caus
restrict
repertoir
hand
distant
crossreact
clonotyp
present
low
frequenc
absenc
high
frequenc
high
affin
clone
allow
ampl
space
develop
repertoir
divers
continu
analys
cell
respons
ebv
aim
patient
immun
control
reveal
whole
network
crossreact
ebvencod
iavencod
epitop
much
like
k
b
restrict
network
crossreact
discuss
lcmv
vv
pvencod
epitop
figur
note
crossreact
cell
found
subject
other
like
reveal
strong
role
privat
specif
process
dengu
virus
close
relat
virus
found
four
serotyp
neutral
assay
virus
serolog
crossreact
encod
crossreact
cell
epitop
sever
manifest
dengu
diseas
dengu
hemorrhag
fever
shock
syndrom
commonli
present
individu
immun
one
strain
serotyp
dengu
viru
becom
infect
anoth
strain
long
thought
due
crossreact
nonneutr
antibodi
bind
virus
without
inactiv
instead
enhanc
infect
cell
like
macrophag
bear
fc
receptor
process
known
immun
enhanc
howev
may
part
mechan
extens
cell
crossreact
occur
virus
tabl
one
report
show
substanti
part
cell
respons
second
dengu
viru
infect
consist
cell
higher
affin
previous
encount
dengu
viru
one
caus
current
infect
thu
combin
enhanc
viral
load
due
antibodydepend
immun
enhanc
plu
crossreact
low
affin
cell
respons
may
help
contribut
sever
diseas
anoth
compon
immun
system
play
import
role
modul
viral
load
immunopatholog
regulatori
cell
regulatori
cell
treg
gener
thymu
refer
natur
treg
cell
differenti
cell
treg
cell
peripher
tissu
refer
induc
adapt
treg
cell
treg
cell
suppress
function
mani
type
immun
cell
includ
cell
b
cell
dc
nk
nkt
cell
base
factor
cell
gener
thymu
peripheri
cytokin
releas
treg
cell
divid
differ
subtyp
studi
type
natur
treg
cell
make
peripher
cell
popul
play
import
role
protect
host
autoimmun
diseas
like
coliti
gastriti
type
diabet
uniqu
featur
express
forkhead
wingedhelix
famili
transcript
factor
nuclear
transcript
factor
play
critic
role
develop
function
also
highli
depend
exogen
surviv
peripheri
heterolog
immun
iav
lcmv
quit
complic
iavimmun
mice
develop
enhanc
replic
lcmv
enhanc
immun
patholog
lung
character
massiv
consolid
mononuclear
pneumonia
bronchiol
instead
mild
lymphocyt
pneumon
observ
lcmv
infect
mice
memori
cell
deplet
studi
indic
enhanc
lcmv
titer
seem
depend
iavspecif
memori
cell
perhap
regul
cell
enhanc
immun
patholog
caus
crossreact
iavspecif
cell
respons
wlodarczyk
selin
lk
unpublish
system
regulatori
cell
stimul
iav
infect
might
influenc
respons
lcmv
enhanc
number
treg
phenotyp
cell
found
lung
drain
lymph
node
iav
infect
deplet
cell
mab
decreas
lung
patholog
induc
lcmv
infect
kraft
selin
lk
unpublish
autoimmun
diseas
initi
infect
anim
virus
encod
cell
epitop
crossreact
self
antigen
infect
recombin
virus
encod
engin
selfepitop
review
elsewher
instanc
murin
model
autoimmun
kerat
cell
specif
epitop
express
protein
crossreact
corneal
antigen
mous
model
ms
class
ii
epitop
myelin
basic
protein
describ
induc
autoimmun
enceph
eae
human
predispos
autoimmun
diabet
target
autoantigen
glutam
acid
decarboxylas
cell
respons
found
crossreact
epitop
sequenc
similar
autoantigen
cmvencod
antigen
presenc
crossreact
respons
recogn
self
pathogen
antigen
necessarili
lead
autoimmun
need
precipit
event
viral
infect
transgen
mice
express
viral
protein
self
antigen
use
studi
abil
viral
infect
break
toler
lcmv
infect
induc
transient
pancreat
enceph
depend
model
mice
express
lcmv
nucleoprotein
pancrea
brain
subsequ
heterolog
infect
pv
vv
crossreact
epitop
lcmv
induc
second
wave
inflamm
insul
model
lcmv
infect
could
break
toler
induc
insul
subsequ
pv
infect
via
activ
crossreact
cell
push
mous
diabet
similar
phenomenon
may
occur
induct
ms
mice
infect
vv
encod
cn
protein
plp
clear
viru
challeng
subsequ
murin
cmv
develop
cn
white
matter
lesion
human
sever
virus
encod
polyarginin
sequenc
recogn
cell
isol
cn
patient
ms
thu
heterolog
immun
may
play
import
role
induct
autoimmun
diseas
diabet
ms
first
viru
encod
selflik
epitop
break
toler
initi
autoimmun
process
subsequ
second
viru
amplifi
crossreact
respons
push
self
reactiv
cell
respons
certain
threshold
presenc
strong
inflammatori
respons
shift
control
respons
overt
autoimmun
diseas
heterolog
immun
may
common
event
human
infect
help
explain
variabl
diseas
outcom
asymptomat
death
differ
individu
expos
pathogen
may
occur
diseas
ebvassoci
mononucleosi
immunopatholog
featur
pronounc
young
adult
children
diseas
associ
mark
variat
pathogenesi
dengu
hcv
virus
exist
relat
serotyp
eg
dengu
entero
papillomavirus
hpv
quasispeci
variat
cell
epitop
eg
hiv
hcv
persist
infect
constant
stimul
antigen
may
alter
immun
pathogen
heterolog
immun
may
also
factor
unusu
respons
vaccin
particularli
vaccin
design
induc
strong
cell
respons
adult
highli
develop
memori
pool
young
children
frequent
get
multicompon
vaccin
human
vaccin
sometim
lead
erythema
nodosum
form
pannicul
inflamm
fat
tissu
see
acut
fatti
necrosi
afn
abdomin
fat
pad
experiment
condit
heterolog
immun
mice
recent
adenoviru
vectorbas
vaccin
hiv
anoth
exampl
vaccine
higher
initi
antibodi
titer
adenoviru
respond
poorli
less
protect
immun
hiv
suggest
heterolog
immun
may
affect
outcom
peptid
vaccin
hcv
current
construct
includ
epitop
crossreact
hcv
iav
tell
affect
immun
respons
live
viru
challeng
data
show
complic
individu
vaccin
hpv
includ
pannicul
mani
close
relat
strain
mani
parent
refus
vaccin
children
due
perceiv
sever
patholog
side
effect
vaccin
best
antivir
vaccin
attenu
virus
stimul
cell
respons
insight
heterolog
immun
necessari
intellig
design
effect
modern
vaccin
without
unwant
side
effect
contend
heterolog
immun
norm
rather
except
human
viral
infect
manifest
heterolog
immun
may
vari
viru
sequenc
host
would
predict
gener
principl
heterolog
immun
elucid
ultim
manipul
better
understand
heterolog
immun
influenc
viral
immunopathogenesi
could
lead
potenti
therapeut
intervent
circumv
sever
diseas
may
contribut
develop
autoimmun
syndrom
also
intellig
design
vaccin
increas
patholog
observ
heterolog
immun
may
due
dysregul
tight
balanc
antigen
load
infect
effici
effector
cell
clear
infect
effici
memori
b
cell
respons
clear
viru
rapidli
without
induc
immunopatholog
secondari
infect
fluimmun
lcmvimmun
mice
primari
flu
lcmv
pv
respons
viru
clear
slowli
lead
immunopatholog
effici
cell
respons
diminish
low
affin
crossreact
memori
cell
viru
clear
slower
give
time
recruit
mani
memori
effector
cell
induc
immunopatholog
collater
damag
produc
fasl
seen
lcmvimmun
mice
challeng
vv
viral
load
becom
extrem
high
rapidli
result
clonal
exhaust
cell
respons
littl
immunopatholog
seen
high
dose
lcmv
infect
sequenc
heterolog
viru
infect
influenc
viral
clearanc
histopatholog
crossreact
virus
human
